1927.6000 72.90 (3.93%)
NSE Sep 04, 2026 15:31 PM
Volume: 276.6K
 

1927.60
3.93%
ICICI Direct
Niche focus, strategic alliances/ acquisitions at the fore - Pune headquartered Emcure Pharmaceuticals is a diversified pharma player focused on developing, manufacturing and marketing a broad range of pharmaceutical products...
ICICI Direct released a Buy report for Emcure Pharmaceuticals Ltd. with a price target of 2305.0 on 04 Sep, 2026.
More from Emcure Pharmaceuticals Ltd.
Recommended